HyperArc Registry Study

Study Purpose

The HyperArc registry is designed to collect data from which the efficacy of the HyperArc procedure can be assessed and compared to alternative treatments.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational [Patient Registry]
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Received or scheduled to receive treatment using the HyperArc treatment method.
  • - Age of legal adult according to local law.
  • - Signed informed consent form, or, informed consent waived by the local ethics board/institutional review board.

Exclusion Criteria:

- None, apart from not meeting Inclusion Criteria

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT05270707
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Varian, a Siemens Healthineers Company
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

N/A
Principal Investigator Affiliation N/A
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Recruiting
Countries Australia, United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Brain Metastases, CNS Neoplasm, CNS Disorder, Intracranial
Additional Details

A significant percentage of newly diagnosed cancer patients will develop brain metastases. For many of these patients, stereotactic radiosurgery (SRS) is recommended as a primary treatment option. Concerns about complexity, patient safety, cost, and human resources can make SRS challenging. HyperArc radiotherapy addresses these challenges by introducing key technology and workflow elements to streamline multi-leaf collimator-based, non-coplanar SRS. HyperArc is designed to deliver SRS treatments from the TrueBeam linear accelerator platform. The HyperArc registry is designed to collect data from which the efficacy of the HyperArc procedure can be assessed and compared to alternative treatments.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

University of Alabama, Birmingham, Alabama

Status

Recruiting

Address

University of Alabama

Birmingham, Alabama, 35233

Site Contact

Cindy Perdue

[email protected]

205-996-6147

International Sites

Icon Cancer Centre Canberra, Bruce, Australian Capital Territory, Australia

Status

Not yet recruiting

Address

Icon Cancer Centre Canberra

Bruce, Australian Capital Territory, 2617

Site Contact

Mel Grand

[email protected]

+61 437 067 494

Icon Cancer Centre Greenslopes, Greenslopes, Queensland, Australia

Status

Recruiting

Address

Icon Cancer Centre Greenslopes

Greenslopes, Queensland, 4120

Site Contact

Mel Grand

[email protected]

+61 437 067 494

Icon Cancer Centre Maroochydore, Maroochydore, Queensland, Australia

Status

Recruiting

Address

Icon Cancer Centre Maroochydore

Maroochydore, Queensland, 4558

Site Contact

Mel Grand

[email protected]

+61 437 067 494

Icon Cancer Centre Gold Coast Private, Southport, Queensland, Australia

Status

Recruiting

Address

Icon Cancer Centre Gold Coast Private

Southport, Queensland, 4215

Site Contact

Mel Grand

[email protected]

+61 437 067 494

Stay Informed & Connected